Human ovarian tissue cryopreservation: Indications and feasibility

Human Reproduction

Volumn 17, Issue 6, 2002, Pages 1447-1452

  Poirot, Catherine ^a,b   Vacher Lavenu, Marie Cécile ^b   Helardot, Pierre ^c   Guibert, Juliette ^b   Brugières, Laurence ^d   Jouannet, Pierre ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Université Paris V ^*  (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Fertility preservation; Gonadotoxic treatment; Ovarian cryopreservation; Ovarian follicle

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; DIMETHYL SULFOXIDE; SUCROSE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; AUTOGRAFT; CELL COUNT; CHILD; CONCENTRATION (PARAMETERS); CRYOPRESERVATION; CRYOPROTECTION; CYTOTOXICITY; FEASIBILITY STUDY; FEMALE; FEMALE STERILITY; FUNCTIONAL MORPHOLOGY; GONAD; HISTOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LONG TERM CARE; MAJOR CLINICAL STUDY; OVARY DISEASE; OVARY FOLLICLE; OVARY FOLLICLE CELL; PRIMORDIAL GERM CELL; RISK ASSESSMENT; TREATMENT INDICATION; AUTOTRANSPLANTATION; FEMALE INFERTILITY; INFERTILITY THERAPY; METHODOLOGY; NEOPLASM; OVARY; PREMATURE OVARIAN FAILURE; PRESCHOOL CHILD; TISSUE PRESERVATION; TRANSPLANTATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CRYOPRESERVATION; FEMALE; HUMANS; INFERTILITY, FEMALE; NEOPLASMS; OVARIAN FAILURE, PREMATURE; OVARY; REPRODUCTIVE TECHNIQUES, ASSISTED; TISSUE PRESERVATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 0035988388     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.6.1447     Document Type: Article

References (26)

1. Report of the French experience concerning 26 children transplanted for severe Sickle cell disease
2. Infertility and premature menopause in childhood cancer survivors
3. Development of oocytes banks and systems for the in-vitro development of oocytes: Future directions for the treatment of infertility
4. Pregnancy after human oocyte cryopreservation
5. Childhood cancer: Improved prospects for survival but is prevention possible?
6. Human oocyte cryopreservation: New perspectives regarding oocyte survival
7. Incidence of chromosome anomalies in first-cleavage mouse embryos obtained from frozen-thawed oocytes fertilized in vitro
8. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196°C
9. Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose as cryoprotectants
10. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer
11. Cryopreservation in human assisted reproduction is now routine for embryos but remains a research procedure for oocytes
12. Reproduction post-chemotherapy in young cancer patients
13. Low temperature storage and grafting of human ovarian tissue
14. Permeation of human ovarian tissue with cryprotective agents in preparation for cryopreservation
15. Ovarian tissue cryopreservation and transplantation: Preliminary findings and implications for cancer patients
16. Ovarian function after transplantation of frozen, banked autologous ovarian tissue
17. Proliferating cell nuclear antigen marks the initiation of follicular growth in the rat
18. Cryopreservation of immature human oocytes and ovarian tissue: An emerging technology?
19. Reproductive technologies 1998: Options available for the cancer patient
20. Birth of healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes
21. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma
22. Ovarian failure in long-term survivors of childhood malignancy
23. Outcome assessment in cancer management
24. The adverse effects of hormone replacement therapy
25. Ovarian function after autologous bone marrow transplantation in childhood: High-dose busulfan is a major cause of ovarian failure
26. Cryopreservation of human embryos at the pronucleate, early cleavage, or expanded blastocyst stages